Press release
Pancreatic Neuroendocrine Tumors (pNET) Market Expected to Reach USD 2.8 Billion by 2034
Pancreatic neuroendocrine tumors (pNETs) are a rare subset of neuroendocrine tumors that arise from hormone-producing cells in the pancreas. Unlike the more common pancreatic adenocarcinomas, pNETs tend to progress more slowly, though aggressive cases do occur. These tumors can be functional (hormone-secreting) or non-functional, creating complex challenges in diagnosis and treatment.Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71609
Over the past decade, the management of pNETs has evolved considerably. Treatments such as somatostatin analogs, targeted therapies (everolimus, sunitinib), peptide receptor radionuclide therapy (PRRT), and chemotherapy have transformed patient outcomes. With better imaging, improved biomarkers, and ongoing clinical research, the pNET market is witnessing steady global expansion.
Market Overview
The global pancreatic neuroendocrine tumors (pNET) market was valued at USD 1.5 billion in 2024 and is expected to reach USD 2.8 billion by 2034, growing at a CAGR of 6.7% during the forecast period.
Key Highlights:
• Rising incidence of pNETs due to improved diagnostics.
• Increasing use of targeted therapies and PRRT as frontline treatments.
• Strong clinical pipeline with immunotherapies and combination regimens.
• Expanding access to rare disease therapies in emerging economies.
• Challenges include high treatment costs, low awareness, and limited specialized treatment centers.
Leading Players include Novartis, Ipsen, Pfizer, Advanced Accelerator Applications (Novartis subsidiary), Chiasma, Bristol Myers Squibb, Roche, Merck & Co., and Amgen, who are driving innovation in pNET care.
Segmentation Analysis
By Product
• Somatostatin Analogs (octreotide, lanreotide)
• Targeted Therapies (everolimus, sunitinib, novel TKIs in trials)
• Peptide Receptor Radionuclide Therapy (PRRT)
• Chemotherapy Agents
• Immunotherapies (checkpoint inhibitors in development)
• Supportive Care
By Platform
• Biologics
• Small Molecules
• Radiopharmaceuticals
• Biosimilars
By Technology
• PRRT Platforms
• Monoclonal Antibody Therapy
• Biomarker-Based Diagnostic Tools
• Gene and Cell Therapy Approaches (pipeline research)
By End Use
• Hospitals & Specialty Oncology Centers
• Ambulatory Care Clinics
• Research Institutes
• Home-Based Care (supportive and palliative)
By Application
• Functional pNETs (hormone-secreting)
• Non-Functional pNETs
• Advanced/Metastatic pNETs
• Refractory/Relapsed Cases
Summary:
Somatostatin analogs remain the cornerstone of therapy, but PRRT and targeted therapies such as everolimus and sunitinib are driving the most significant growth through 2034. Radiopharmaceuticals and biologics are positioned as the most innovative platforms, while biomarker-driven technologies are shaping precision oncology strategies for pNETs.
Explore Full Report here: https://exactitudeconsultancy.com/reports/71609/pancreatic-neuroendocrine-tumors-pnet-market
Regional Analysis
North America
• Largest share of the pNET market, led by the United States.
• High adoption of PRRT and targeted therapies.
• Favorable reimbursement policies and robust clinical research ecosystem.
Europe
• Strong presence in PRRT adoption and rare disease treatment infrastructure.
• Germany, France, and the UK are leading contributors, supported by government funding.
Asia-Pacific
• Fastest-growing region due to rising cancer awareness, increasing diagnosis rates, and investments in oncology care.
• China, Japan, and India are key markets with growing clinical trial activity.
Middle East & Africa
• Smaller but steadily growing market.
• Limited access to novel therapies but improving with healthcare modernization.
Latin America
• Moderate growth driven by Brazil and Mexico.
• Expanding oncology programs supported by public and private partnerships.
Summary:
While North America and Europe dominate the current market, Asia-Pacific is projected to post the highest CAGR from 2024 to 2034, driven by large patient pools, expanding infrastructure, and rising healthcare spending.
Market Dynamics
Growth Drivers
• Rising global incidence of pNETs due to better detection and awareness.
• Expanding use of somatostatin analogs, PRRT, and targeted therapies.
• Strong pipeline of innovative drugs, including immunotherapies.
• Growing investments in rare disease research and patient advocacy.
Challenges
• High costs of PRRT and targeted biologics.
• Limited diagnostic awareness in low-income regions.
• Lack of specialized treatment centers in many emerging markets.
Latest Trends
• Increasing approvals and use of radiopharmaceutical therapies.
• Precision medicine approaches, including biomarker-based patient selection.
• Clinical trials exploring combination therapies (PRRT + targeted agents).
• Rise of biosimilars to expand patient access.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71609
Competitive Landscape
Key Market Players:
• Novartis AG (Sandostatin, Lutathera)
• Ipsen (Somatuline Depot)
• Advanced Accelerator Applications (Novartis)
• Pfizer Inc.
• Chiasma, Inc.
• Amgen
• Roche Holding AG
• Bristol Myers Squibb
• Merck & Co.
• Eli Lilly and Company
Competition is shaped by leadership in somatostatin analogs and PRRT, clinical pipeline development, and regional expansion. Novartis remains the market leader with Sandostatin and Lutathera, while Ipsen continues to strengthen its position with Somatuline Depot. New entrants focusing on immuno-oncology and gene-based therapies are intensifying the innovation landscape.
Conclusion
The pancreatic neuroendocrine tumors market is entering a phase of accelerated innovation and expansion. With the global market projected to grow at a CAGR of 6.7 % between 2024 and 2034, opportunities abound for pharmaceutical companies, diagnostic providers, and healthcare institutions.
Key opportunities include:
• Expansion of PRRT adoption across high- and middle-income markets.
• Growth in biomarker-driven precision medicine for pNETs.
• Development of cost-effective biosimilars to improve global access.
• Rising investments in Asia-Pacific's oncology infrastructure.
As awareness, diagnosis, and therapeutic options improve, the pNET market is set to deliver stronger survival outcomes for patients while providing robust opportunities for global healthcare stakeholders.
This report is also available in the following languages : Japanese (膵神経内分泌腫瘍(PNET)市場), Korean (췌장 신경내분비 종양(PNET) 시장), Chinese (胰腺神经内分泌肿瘤(PNET)市场), French (Marché des tumeurs neuroendocrines pancréatiques (PNET)), German (Markt für neuroendokrine Tumoren der Bauchspeicheldrüse (PNET)), and Italian (Mercato dei tumori neuroendocrini pancreatici (PNET)), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71609/pancreatic-neuroendocrine-tumors-pnet-market#request-a-sample
Our More Reports:
Alzheimer's Disease Market
https://exactitudeconsultancy.com/reports/72097/alzheimer-s-disease-market
Cell and Gene Therapy in Parkinson's Disease- Market
https://exactitudeconsultancy.com/reports/72098/cell-and-gene-therapy-in-parkinson-s-disease-market
Dementia with Lewy Bodies Patient Pool Analysis, Market
https://exactitudeconsultancy.com/reports/72099/dementia-with-lewy-bodies-patient-pool-analysis-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pancreatic Neuroendocrine Tumors (pNET) Market Expected to Reach USD 2.8 Billion by 2034 here
News-ID: 4173953 • Views: …
More Releases from Exactitude Consultancy

Vacuum Insulated Pipe Market Projected to Reach USD 2.36 Billion by 2034
Introduction: A Market Built on Cryogenic Efficiency and Innovation
The global Vacuum Insulated Pipe (VIP) market is witnessing a steady surge driven by the expanding cryogenic industry, increased liquefied natural gas (LNG) trade, and rising demand for efficient liquid gas transportation systems. These specialized double-wall pipes, engineered with high vacuum insulation between inner and outer layers, have become indispensable in industries handling cryogenic fluids such as liquid nitrogen, oxygen, argon, and…

Solar PV Mounting Systems Market is Expected to Reach USD 31.7 Billion by 2034
Introduction: Powering the Next Decade of Solar Expansion
The Solar PV Mounting Systems Market is emerging as a crucial pillar in the clean energy revolution, enabling efficient, cost-effective, and durable installations of photovoltaic (PV) modules across rooftops, open fields, and floating structures. As the world accelerates toward carbon neutrality, the demand for robust, modular, and adaptable mounting systems has intensified across residential, commercial, and utility-scale solar projects.
Download Full PDF Sample Copy…

Tall Oil Fatty Acid Market projected to reach USD 2.21 billion by 2034
Introduction: A Sustainable Feedstock Powering the Future of Bio-based Chemicals
The Tall Oil Fatty Acid (TOFA) Market is gaining strong traction as industries increasingly shift toward renewable, sustainable, and bio-based chemical alternatives. Derived as a byproduct from the kraft pulping process of pine wood, TOFA has become a vital raw material in the production of alkyd resins, dimer acids, lubricants, coatings, and adhesives. Its unique composition-rich in oleic and linoleic acids-makes…

Lithium-Ion Battery Recycling Market Projected to Reach USD 27.3 Billion by 2034
Introduction: Powering the Circular Energy Transition
As the world accelerates toward electrification and clean energy, the demand for lithium-ion batteries has skyrocketed-fueling everything from electric vehicles (EVs) to smartphones and grid storage systems. However, this exponential growth brings with it an urgent environmental challenge: how to sustainably manage end-of-life batteries.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/25354
The Lithium-Ion Battery Recycling Market has emerged as a cornerstone of the global…
More Releases for PRRT
Peptide Receptor Radionuclide Therapy (PRRT) Market Growth in Future Scope 2025- …
Peptide Receptor Radionuclide Therapy (PRRT) Market Trends Overview 2025-2032:
A new Report by Coherent Market Insights, titled "Peptide Receptor Radionuclide Therapy (PRRT) Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032," offers a comprehensive analysis of the industry, which comprises insights on the Peptide Receptor Radionuclide Therapy (PRRT) market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
Global Peptide Receptor Radionuclide Therapy (PRRT) Market…
Peptide Receptor Radionuclide Therapy (PRRT) Market Is Booming Worldwide 2024-20 …
Latest Report, titled "Peptide Receptor Radionuclide Therapy (PRRT) Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The keyword market has been…
Peptide Receptor Radionuclide Therapy (PRRT) Market 2024 Opportunities, Business …
Peptide Receptor Radionuclide Therapy (PRRT) Market Growing Demand and Growth Opportunity 2024-2031:
Coherent Market Insights offers a latest published report on "Peptide Receptor Radionuclide Therapy (PRRT) Market analysis and Forecast 2024 - 2031" delivering key insights and providing a competitive advantage to clients through a detailed report. The report highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
It is a professional and…
Peptide Receptor Radionuclide Therapy (PRRT) Market Generated Opportunities, Fut …
Coherent Market Insights introduces new research on the Peptide Receptor Radionuclide Therapy (PRRT) Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The…
Peptide Receptor Radionuclide Therapy (PRRT) Market is expected to exhibit a CAG …
Peptide Receptor Radionuclide Therapy (PRRT) Market: An in-depth analysis of statistics on current and emerging trends provides clarity regarding Peptide Receptor Radionuclide Therapy (PRRT) Market dynamics. The report includes Porter's five forces to analyze the importance of various characteristics such as understanding of suppliers and customers, risks posed by various agents, competitive strength, and promising emerging businessmen to understand a resource. precious. Further, the report covers the Peptide Receptor Radionuclide…
Peptide Receptor Radionuclide Therapy (PRRT) Market Study Growth Factors, Types …
The worldwide Peptide Receptor Radionuclide Therapy (PRRT) report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner…